Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
Clinical trial NCT04681287 · UNKNOWN
Trial details
- NCT number
- NCT04681287
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2021-11-04
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.